%0 Journal Article
%A Benito Villalvilla, Cristina
%A Pérez Diego, Mario
%A Angelina Querencias, Alba
%A Kisand, Kai
%A Rebane, Ana
%A Subiza, José Luis
%A Palomares Gracia, Óscar
%T Allergoid–mannan conjugates reprogram monocytes into tolerogenic dendritic cells via epigenetic and metabolic rewiring
%D 2022
%@ 0091-6749
%U https://hdl.handle.net/20.500.14352/71283
%X Allergoid–mannan conjugates are novel vaccines for allergen-specific immunotherapy being currently assayed in phase 2 clinical trials. Allergoid–mannan conjugates target dendritic cells (DCs) and generate functional forkhead box P3 (FOXP3)-positive Treg cells, but their capacity to reprogram monocyte differentiation remains unknown.
%~